COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics Receives Notice of Allowance for New Patent by U.S. Patent and Trademark Office that Further Strengthens Intellectual Property Portfolio Around Tedopi® in Immuno-Oncology Applications
25/01/2018
NANTES, France, Jan. 25, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for [...]
ProMIS Neurosciences to Present at Upcoming Investor Conferences
25/01/2018
TORONTO and CAMBRIDGE, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today [...]
Exagen Diagnostics announces collaboration with GSK to drive greater awareness about challenges facing lupus diagnosis and management
25/01/2018
ALBUQUERQUE, NM and SAN DIEGO, CA, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, Inc. today announced a first-of-its kind collaboration with GSK to raise awareness of its laboratory tests, which facilitate early [...]
Nextech Highlights NexCloud for Medical Spas at the American Med Spa Association Show
25/01/2018
TAMPA, Fla., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, will present its leading aesthetic medicine cloud technology for [...]
Zealand Pharma hosts Capital Market Day: Accelerating the late stage pipeline
25/01/2018
Press release - No. 2/2017 Zealand Pharma hosts Capital Market Day: Accelerating the late stage pipeline Four late stage programs with best-in-class potential and attractive risk profiles for rare diseases and diabetes [...]
ArmadaCare Appoints New Vice President of National Accounts
25/01/2018
BALTIMORE, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ArmadaCare, a supplemental insurance company, recently appointed Matthew Mattice to its newly created position, Vice President of National Accounts, to help address the [...]
Woebot Labs Launches Mobile App for iOS - Expanding Reach and Capability of Mental Health Chatbot
25/01/2018
SAN FRANCISCO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Woebot Labs, Inc. today launched Woebot for iOS on the Apple iTunes Store. Woebot is the only mental health chatbot that is clinically shown to reduce symptoms of mood- [...]
Tempus and NYU School of Medicine Announce New Initiative to Help Improve Outcomes for Pancreatic Cancer Patients
25/01/2018
CHICAGO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, today announced a [...]
UPDATE -- DLT Resolution to acquire 80% of fast growing Canadian start-up A.J.D. Data Services Ltd.
25/01/2018
LAS VEGAS, NV, Jan. 25, 2018 (GLOBE NEWSWIRE) -- DLT Resolution Inc. (OTC: DLTI), a blockchain technology and data services company providing distributed ledger technology that currently services the healthcare and [...]
Mariner Endosurgery Receives Health Canada Investigational Testing Approval for LaparoGuard Technology
25/01/2018
Hamilton, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Mariner Endosurgery Inc., an innovative Canadian medical device company leading commercialization of computer-assisted medical devices for laparoscopic surgeries, announced [...]
American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure
25/01/2018
ROCKVILLE, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its HIV Functional Cure [...]
UPDATE -- Breathtec Biomedical Provides Development Update on Breathalyzer for Disease Detection
25/01/2018
VANCOUVER, British Columbia, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Please note this is an Official Company News Release. Breathtec Biomedical Inc. (CSE:BTH) (CNSX: BTH ) (FRANKFURT: BTI ) (OTCQB:BTHCF) (the “Company”) is [...]
Zosano Announces Results of Special Meeting of Stockholders and 1-for-20 Reverse Stock Split
25/01/2018
FREMONT, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
ArmadaCare Announces a New Suite of Supplemental Insurance Products
25/01/2018
HUNT VALLEY, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ArmadaCare has launched a new suite of supplemental insurance products, further strengthening its market-leading position in the group targeted supplemental health [...]
Novan Announces First Patient Dosed in Phase 2 Molluscum Contagiosum Trial with SB206
25/01/2018
MORRISVILLE, N.C., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced that the first patient has been dosed in the Company's Phase 2 clinical trial to evaluate [...]
Albireo Prices $65.0 Million Public Offering of Common Stock
25/01/2018
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the pricing of its [...]
Golden Leaf Subsidiary, Medical Marijuana Group, Receives First Shipment of Genetics to its Grow Facility in St. Thomas, Ontario
25/01/2018
TORONTO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that its [...]
Marrone Bio Innovations Announces Distribution Partnership in the Philippines
25/01/2018
DAVIS, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental [...]
Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs
25/01/2018
NORCROSS, Ga., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins to treat non-alcoholic steatohepatitis (NASH) cirrhosis [...]

Pages